MicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivity

124Citations
Citations of this article
94Readers
Mendeley users who have this article in their library.

Abstract

Over the past decade, research has shown that aberrant expression of microRNA (miRNA) is involved in colorectal cancer development and progression. MicroRNAs are small sequences of non-coding RNA that regulate expression of genes involved in important cellular functions, such as cell differentiation, multiplication, and apoptosis. A specific miRNA may display the effects of a tumor suppressor or oncogene. Altered miRNA expression is found in colorectal cancer (CRC) and patterns of miRNA expression correlate with CRC detection and outcome. Studies also have examined the use of circulating serum miRNA and fecal miRNA expression as non-invasive markers for early detection. Here, we review recent evidence demonstrating the potential role of miRNA in CRC and the implications of its use in the diagnosis, prognosis, and management of CRC.

Cite

CITATION STYLE

APA

Hollis, M., Nair, K., Vyas, A., Chaturvedi, L. S., Gambhir, S., & Vyas, D. (2015). MicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivity. World Journal of Gastroenterology, 21(27), 8284–8292. https://doi.org/10.3748/wjg.v21.i27.8284

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free